Reza Mohammadi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Reza Mohammadi has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Mohammadali Bagherinasabsarab
Department of Urology, Kerman University of Medical Sciences, Kerman, Iran
2 shared publications Abbas Poorjafari
Urologist, Department of Urology, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication- Ali Kamalati
Clinical Research Development Unit, Shahid Bahonar Hospital, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication - Behzad Lotfi
Department of Urology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
1 shared publication - Elham Jafari
Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication Fatemeh Yazdanpanah
Department of Dermatology, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication
Latest Publications
- 7 February 2026
- Published by Maad Rayan Publishing Company in Journal of Kerman University of Medical Sciences
- Vol. 33 (1) , 1-5
A Very Large Asymptomatic and Biochemically Negative Incidentaloma Further Diagnosed as Pheochromocytoma: A Case Report
Background: Pheochromocytoma and Paraganglioma can secrete excess Catecholamines, causing hypertension, tachycardia, hyperhidrosis, or shock. Measuring blood and urine Metanephrine levels helps with a proper diagnosis. Tumor localization can be performed using Magnetic Resonance Imaging (MRI) or Computed Tomography (CT). Tumors can also present as an asymptomatic adrenal incidentaloma, identified radiographically. Here, we report one such interesting case. Case report: A 48-year-old woman was referred to us with an 8.9 × 9.4 cm right adrenal incidentaloma, as measured by computed tomography (CT) scan. She was totally asymptomatic, with normal blood pressure both before and after the operation. Repeated biochemical screening remained within normal range. The patient underwent right adrenalectomy (via a subcostal incision), and histological findings confirmed Pheochromocytoma. Conclusion: This case illustrates how radiologic findings in an asymptomatic and biochemically negative patient can alert to the presence of a Pheochromocytoma.
- 7 February 2026
- Published by Maad Rayan Publishing Company in Journal of Kerman University of Medical Sciences
- Vol. 33 (1) , 1-5
A Very Large Asymptomatic and Biochemically Negative Incidentaloma Further Diagnosed as Pheochromocytoma: A Case Report
Background: Pheochromocytoma and Paraganglioma can secrete excess Catecholamines, causing hypertension, tachycardia, hyperhidrosis, or shock. Measuring blood and urine Metanephrine levels helps with a proper diagnosis. Tumor localization can be performed using Magnetic Resonance Imaging (MRI) or Computed Tomography (CT). Tumors can also present as an asymptomatic adrenal incidentaloma, identified radiographically. Here, we report one such interesting case. Case report: A 48-year-old woman was referred to us with an 8.9 × 9.4 cm right adrenal incidentaloma, as measured by computed tomography (CT) scan. She was totally asymptomatic, with normal blood pressure both before and after the operation. Repeated biochemical screening remained within normal range. The patient underwent right adrenalectomy (via a subcostal incision), and histological findings confirmed Pheochromocytoma. Conclusion: This case illustrates how radiologic findings in an asymptomatic and biochemically negative patient can alert to the presence of a Pheochromocytoma.
- 20 August 2023
- Published by Maad Rayan Publishing Company in Journal of Kerman University of Medical Sciences
- Vol. 30 (4) , 213-217
Does Repeating Transurethral Resection of Bladder Tumors Change Treatment Plan for All T1 Tumors?
Background: The main problem in the proper management of non-muscle invasive bladder cancer (NMIBC) is the under-staging of lesions after initial transurethral resection of bladder tumor (TUBRT). Under staging is much more evident in T1 tumors when the detrusor muscle is absent. So, we evaluated under-staging and residual tumors in patients with complete initial TURBT whose initial pathological samples revealed the presence of the detrusor muscle. Methods: In this prospective study performed in Bahonar hospital, Kerman, Iran, from August 2018 to April 2020, 51 patients with newly diagnosed T1 bladder tumors were enrolled according to our criteria and underwent standard Re-TURBT about eight weeks after the initial TURBT. Results: Of 51 patients who underwent Re-TURBT, 12 (23.5%) had tumors, of whom eight had microscopic, and four had macroscopic tumors. None of them were upstaged or upgraded. There was a statistically significant relationship between the presence of tumors in Re-TURBT and the size of the primary tumor (>3 cm) and the number of tumors (>1). No changes were observed in the stage and grade of the disease, besides, the treatment plan of patients did not change despite imposing financial burdens on patients and the healthcare system. Conclusion: Re-TURBT is not necessary for all superficial bladder tumors, especially in the case of complete initial TURBT, and also in the presence of the detrusor muscle in the pathological sample and when the tumor is single and less than three centimeters in size.
- 20 August 2023
- Published by Maad Rayan Publishing Company in Journal of Kerman University of Medical Sciences
- Vol. 30 (4) , 213-217
Does Repeating Transurethral Resection of Bladder Tumors Change Treatment Plan for All T1 Tumors?
Background: The main problem in the proper management of non-muscle invasive bladder cancer (NMIBC) is the under-staging of lesions after initial transurethral resection of bladder tumor (TUBRT). Under staging is much more evident in T1 tumors when the detrusor muscle is absent. So, we evaluated under-staging and residual tumors in patients with complete initial TURBT whose initial pathological samples revealed the presence of the detrusor muscle. Methods: In this prospective study performed in Bahonar hospital, Kerman, Iran, from August 2018 to April 2020, 51 patients with newly diagnosed T1 bladder tumors were enrolled according to our criteria and underwent standard Re-TURBT about eight weeks after the initial TURBT. Results: Of 51 patients who underwent Re-TURBT, 12 (23.5%) had tumors, of whom eight had microscopic, and four had macroscopic tumors. None of them were upstaged or upgraded. There was a statistically significant relationship between the presence of tumors in Re-TURBT and the size of the primary tumor (>3 cm) and the number of tumors (>1). No changes were observed in the stage and grade of the disease, besides, the treatment plan of patients did not change despite imposing financial burdens on patients and the healthcare system. Conclusion: Re-TURBT is not necessary for all superficial bladder tumors, especially in the case of complete initial TURBT, and also in the presence of the detrusor muscle in the pathological sample and when the tumor is single and less than three centimeters in size.
- Open Access
- 21 February 2023
- Published by Maad Rayan Publishing Company in Journal of Kerman University of Medical Sciences
- Vol. 30 (1) , 55-57
Renal Angiomyolipoma Associated with Renal Vein and Inferior Vena Cava Thrombosis: A Case Report
Angiomyolipoma (AML) is the most common benign renal mesenchymal neoplasm. This is a report of a 36-year-old female patient with AML with the involvement of the inferior vena cava (IVC) who was admitted to our hospital. The patient complained of mild right flank pain. CT scan results showed a hypo-dense mass with 47×72 mm dimensions at the right kidney›s lower pole suggesting renal AML. In MRI with contrast, venous thrombosis was detected in the right renal vein and IVC. Right radical nephrectomy and IVC thrombectomy were successfully conducted. Renal AML was confirmed by pathological findings, and the presence of tumor thrombosis was approved in the right renal vein and IVC. Although AML is generally benign and vascular invasion is a rare finding in this condition, imaging studies (including CT scans) should always be considered to determine the extent of vascular involvement and choose an appropriate therapeutic plan, including nephrectomy and thrombectomy in case of vascular involvement. Despite its benign nature, it should be considered that AML can invade venous structures in the kidneys. Early imaging studies and therapeutic interventions are necessary for obtaining the best outcome.
- 21 February 2023
- Published by Maad Rayan Publishing Company in Journal of Kerman University of Medical Sciences
- Vol. 30 (1) , 55-57
Open AccessRenal Angiomyolipoma Associated with Renal Vein and Inferior Vena Cava Thrombosis: A Case Report
Angiomyolipoma (AML) is the most common benign renal mesenchymal neoplasm. This is a report of a 36-year-old female patient with AML with the involvement of the inferior vena cava (IVC) who was admitted to our hospital. The patient complained of mild right flank pain. CT scan results showed a hypo-dense mass with 47×72 mm dimensions at the right kidney›s lower pole suggesting renal AML. In MRI with contrast, venous thrombosis was detected in the right renal vein and IVC. Right radical nephrectomy and IVC thrombectomy were successfully conducted. Renal AML was confirmed by pathological findings, and the presence of tumor thrombosis was approved in the right renal vein and IVC. Although AML is generally benign and vascular invasion is a rare finding in this condition, imaging studies (including CT scans) should always be considered to determine the extent of vascular involvement and choose an appropriate therapeutic plan, including nephrectomy and thrombectomy in case of vascular involvement. Despite its benign nature, it should be considered that AML can invade venous structures in the kidneys. Early imaging studies and therapeutic interventions are necessary for obtaining the best outcome.
- Open Access
- 31 July 2016
- Published by Brieflands in Nephro-Urology Monthly
- Vol. 8 (5) , e39726
Supradiaphragmatic Inferior Vena Caval Thrombectomy Without Cardiopulmonary Bypass: A Case Series at a Single Center
Introduction: Inferior vena cava tumor thrombectomy in renal cell carcinoma patients is a challenging procedure, frequently requiring the vascular bypass technique for high-level thrombi with additional complications. Adopting a technique such as intrapericardial control in selected cases will circumvent these problems. Here, we present the results of our intrapericardial control technique during supradiaphragmatic inferior vena caval tumor thrombectomy. Case Presentation: The records of six patients with supradiaphragmatic tumor thrombi, who underwent radical nephrectomy and thrombectomy at our center with intrapericardial control between the years 2008 and 2015, were retrospectively reviewed. The patients’ characteristics, intra- and postoperative data, histology, and follow-up records were gathered and compared. There were no immediate or 30-day postoperative deaths. The mean age of the patients was 61.3 years (range 46 - 75). The total mean duration of surgery was 315 minutes and the mean amount of transfused red blood cells was 4.33 units during surgery and 0.8 units in the postoperative period. The average hospitalization duration was 8 days (range 5 - 17). Tumor stage was T3 in four patients and T4 in two, due to ipsilateral adrenal involvement. The mean duration of follow-up was 33.5 months. Only one of the patients developed recurrences, first in the tumor bed and then at the site of the skin incision; these were excised with no apparent complications. Conclusions: Radical nephrectomy and tumor thrombectomy by intrapericardial control without cardiopulmonary bypass and hypothermic circulatory arrest is a safe and effective procedure that can avoid serious intra- and postoperative complications while providing acceptable cancer-control and mortality results. Keywords: Carcinoma; Renal Cell/Surgery; Vena Cava; Inferior/Surgery; Venous Thrombosis; Cardiopulmonary Bypass; Kidney Neoplasm; Nephrectomy/Methods
- 31 July 2016
- Published by Brieflands in Nephro-Urology Monthly
- Vol. 8 (5) , e39726
Open AccessSupradiaphragmatic Inferior Vena Caval Thrombectomy Without Cardiopulmonary Bypass: A Case Series at a Single Center
Introduction: Inferior vena cava tumor thrombectomy in renal cell carcinoma patients is a challenging procedure, frequently requiring the vascular bypass technique for high-level thrombi with additional complications. Adopting a technique such as intrapericardial control in selected cases will circumvent these problems. Here, we present the results of our intrapericardial control technique during supradiaphragmatic inferior vena caval tumor thrombectomy. Case Presentation: The records of six patients with supradiaphragmatic tumor thrombi, who underwent radical nephrectomy and thrombectomy at our center with intrapericardial control between the years 2008 and 2015, were retrospectively reviewed. The patients’ characteristics, intra- and postoperative data, histology, and follow-up records were gathered and compared. There were no immediate or 30-day postoperative deaths. The mean age of the patients was 61.3 years (range 46 - 75). The total mean duration of surgery was 315 minutes and the mean amount of transfused red blood cells was 4.33 units during surgery and 0.8 units in the postoperative period. The average hospitalization duration was 8 days (range 5 - 17). Tumor stage was T3 in four patients and T4 in two, due to ipsilateral adrenal involvement. The mean duration of follow-up was 33.5 months. Only one of the patients developed recurrences, first in the tumor bed and then at the site of the skin incision; these were excised with no apparent complications. Conclusions: Radical nephrectomy and tumor thrombectomy by intrapericardial control without cardiopulmonary bypass and hypothermic circulatory arrest is a safe and effective procedure that can avoid serious intra- and postoperative complications while providing acceptable cancer-control and mortality results. Keywords: Carcinoma; Renal Cell/Surgery; Vena Cava; Inferior/Surgery; Venous Thrombosis; Cardiopulmonary Bypass; Kidney Neoplasm; Nephrectomy/Methods
- 13 June 2012
- Published by Springer Nature in World Journal of Urology
- Vol. 31 (5) , 1225-1230
A study on comparative outcomes of percutaneous nephrolithotomy in prone, supine, and flank positions
To compare percutaneous nephrolithotomy (PCNL) safety and efficacy in prone, supine, and flank positions. A total number of 150 candidates for PCNL were randomly assigned into prone, supine, and flank groups. Patients in groups 1 and 2 underwent fluoroscopy-guided PCNL in prone and supine positions, respectively, while patients in group 3 underwent ultrasonography-guided PCNL in lateral position. The success rates were 92, 86, and 88 % in prone, supine, and flank positions, respectively (P = 0.7). The mean access duration was 6.9 ± 4.2, 11.1 ± 5.8, and 10.8 ± 4.1 min (P = 0.08), and the mean operation time was 68.7 ± 37.4, 54.2 ± 25.1 and 74.4 ± 26.9 min (P = 0.04) in prone, supine, and flank groups, respectively. Pyelocaliceal perforation occurred in 2 (4 %), 2 (4 %), and 3 (6 %) patients in prone, supine, and flank positions, respectively (P = 1). We believe that PCNL in both supine and flank positions are as safe and relatively effective as prone position in experienced hands. Preference of the surgeon and proper case selection for each procedure is very important and necessary.
- 13 June 2012
- Published by Springer Nature in World Journal of Urology
- Vol. 31 (5) , 1225-1230
A study on comparative outcomes of percutaneous nephrolithotomy in prone, supine, and flank positions
To compare percutaneous nephrolithotomy (PCNL) safety and efficacy in prone, supine, and flank positions. A total number of 150 candidates for PCNL were randomly assigned into prone, supine, and flank groups. Patients in groups 1 and 2 underwent fluoroscopy-guided PCNL in prone and supine positions, respectively, while patients in group 3 underwent ultrasonography-guided PCNL in lateral position. The success rates were 92, 86, and 88 % in prone, supine, and flank positions, respectively (P = 0.7). The mean access duration was 6.9 ± 4.2, 11.1 ± 5.8, and 10.8 ± 4.1 min (P = 0.08), and the mean operation time was 68.7 ± 37.4, 54.2 ± 25.1 and 74.4 ± 26.9 min (P = 0.04) in prone, supine, and flank groups, respectively. Pyelocaliceal perforation occurred in 2 (4 %), 2 (4 %), and 3 (6 %) patients in prone, supine, and flank positions, respectively (P = 1). We believe that PCNL in both supine and flank positions are as safe and relatively effective as prone position in experienced hands. Preference of the surgeon and proper case selection for each procedure is very important and necessary.